Table 2.

Best response (BR) and Clinical Benefit (CB) by fasting glucose and BMI¹ at the time of BR assessment (N:102).

Best Response
	No PD2	PD2	Mann-Whitney
	N = 76	N = 26
	Mean* ± SD	Mean* ± SD	p-value
Fasting glucose at BR	108.9 ± 29.3	122.6 ± 38.0	<0.001
BMI at BR	26.9 ± 5.3	26.1 ± 6.4	0.052
Clinical Benefit
	Yes	No	Student’s T
	N = 41	N = 41
	Mean* ± SD	Mean* ± SD	p-value
Fasting glucose at BR	108.2 ± 29.5	120.5 ± 33.0	<0.001
BMI at BR	26.8 ± 5.4	26.9 ± 5.4	0.895

¹BMI: body mass index.

²PD: Disease Progression.

^*Mean weighted by number of cycles administered.